As pharmaceutical innovation continues to evolve, the interplay between intellectual property protection and public access to medicines remains a defining issue in patent law. This article examines the evolving jurisprudence on secondary pharmaceutical patents, exploring how different jurisdictions balance incentives for innovation with safeguards against the unwarranted extension of patent monopolies. Through a comparative analysis of India's legal framework alongside developments in the United States and Europe, the publication considers the broader policy and legal principles shaping the future of pharmaceutical patent protection.
Read the article here: Article-Secondary Patents
Authors:
Nisha Wadhwa (Principal Associate)
Nishant Veer Vikram Singh (Patent Engineer)
Kanchan Naagar (Trainee Engineer)
Disclaimer:
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.